Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ENvue Medical, Inc. (FEED : NSDQ)

• Company Description    ENvue Medical Holdings Corp. is an electromagnetic navigation technology, providing real-time guidance for enteral feeding tube placement across critical care, step-down units and general medical-surgical floors in hospitals. ENvue Medical Holdings Corp., formerly known as NanoVibronix Inc., is based in ELMSFORD, N.Y. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $1.01 Daily Weekly Monthly 20 Day Moving Average: 703,851 shares Shares Outstanding: 6.09 (millions) Market Capitalization: $6.15 (millions) Beta: 1.59 52 Week High: $16.60 52 Week Low: $0.84 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.63% -28.31% 12 Week -55.31% -58.69% Year To Date -56.28% -62.99%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 969 PRUITT AVE - TYLER,TX 77569 USA ph: 914-233-3004 fax: 914-376-6111 brett@haydenir.com http://www.envuemed.com

• General Corporate Information    Officers Doron Besser - Chief Executive Officer and Director David Johnson - Chairman of the Board Zeev Rotstein - Director Allison Burgett - Director Nino Pionati - Director Peer Information ENvue Medical, Inc. (ABMD) ENvue Medical, Inc. (DMDS) ENvue Medical, Inc. (CPWY.) ENvue Medical, Inc. (EQUR) ENvue Medical, Inc. (ECIA) ENvue Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 63008J884 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/18/26 Share - Related Items Shares Outstanding: 6.09 Most Recent Split Date: 8.00 (0.10:1) Beta: 1.59 Market Capitalization: $6.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/18/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.19 Price/Cash Flow: - Price / Sales: 2.82 EPS Growth vs. Year Ago Period: 82.71% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -36.29% vs. Previous Quarter: 109.29% ROE 03/31/26 - -54.25 12/31/25 - -47.82 09/30/25 - -24.78 ROA 03/31/26 - -43.10 12/31/25 - -38.06 09/30/25 - -19.24 Current Ratio 03/31/26 - 0.90 12/31/25 - 1.09 09/30/25 - 0.86 Quick Ratio 03/31/26 - - 12/31/25 - 0.74 09/30/25 - 0.67 Operating Margin 03/31/26 - -923.20 12/31/25 - -712.30 09/30/25 - -275.12 Net Margin 03/31/26 - -923.20 12/31/25 - -712.30 09/30/25 - -275.12 Pre-Tax Margin 03/31/26 - -936.45 12/31/25 - -724.32 09/30/25 - -270.76 Book Value 03/31/26 - 5.26 12/31/25 - 30.44 09/30/25 - 42.00 Inventory Turnover 03/31/26 - 1.08 12/31/25 - 1.09 09/30/25 - 0.87 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©